
 |
|
 |
 |
 |
Approval Expanded for Breast Cancer Drug Tykerb (HealthDay)
HealthDay - MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug
Administration has expanded approval for Tykerb (lapatinib) to include
postmenopausal women with hormone- and HER2-positive advanced breast
cancer who require hormone therapy. |
 |
House Democrats Approve Health-Care Reform Bill (HealthDay)
HealthDay - SUNDAY, March 21 (HealthDay News) -- After a year of fierce
partisan debate, the Democrat-controlled House of Representatives late
Sunday night passed the landmark $940 billion health-care reform bill,
which would extend health insurance coverage to 32 million uninsured
Americans, prevent insurance companies from denying coverage to people
with preexisting medical conditions and cut the federal deficit by an
estimated $138 billion over the next decade. |
 |
Showdown Over Health-Care Reform Bill Nears (HealthDay)
HealthDay - FRIDAY, March 19 (HealthDay News) -- Health experts say that the
furiously debated $940 billion health-care reform bill moving toward a
vote for passage in Congress this weekend really boils down to one simple
tenet: More Americans should have access to health insurance. |
 |
Gene-Targeted Cancer Fix Could Be a Breakthrough (HealthDay)
HealthDay - SUNDAY, March 21 (HealthDay News) -- For the first time in
humans, scientists have successfully used a gene-manipulation therapy to
enter tumor cells and block the production of toxic proteins that are
causing cancer, researchers report. |
 |
US Congress passes historic health care bill (AFP)
AFP - The US Congress passed an historic health care overhaul Sunday, handing President Barack Obama a landmark win and taking the United States closer than ever to guaranteed coverage for all Americans. |
|
|
 |